321 related articles for article (PubMed ID: 25768649)
1. Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
Bialas J; Groettrup M; Aichem A
PLoS One; 2015; 10(3):e0120329. PubMed ID: 25768649
[TBL] [Abstract][Full Text] [Related]
2. Investigations into the auto-FAT10ylation of the bispecific E2 conjugating enzyme UBA6-specific E2 enzyme 1.
Aichem A; Catone N; Groettrup M
FEBS J; 2014 Apr; 281(7):1848-59. PubMed ID: 24528925
[TBL] [Abstract][Full Text] [Related]
3. UBA6 and Its Bispecific Pathways for Ubiquitin and FAT10.
Wang F; Zhao B
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067743
[TBL] [Abstract][Full Text] [Related]
4. The ubiquitin-like modifier FAT10 covalently modifies HUWE1 and strengthens the interaction of AMBRA1 and HUWE1.
Mueller S; Bialas J; Ryu S; Catone N; Aichem A
PLoS One; 2023; 18(8):e0290002. PubMed ID: 37578983
[TBL] [Abstract][Full Text] [Related]
5. LMO2 blocks the UBA6-USE1 interaction and downstream FAT10ylation by targeting the ubiquitin fold domain of UBA6.
Wu C; Liu Y; Gu X; Zhu T; Yang S; Sun W
Biochem Biophys Res Commun; 2016 Sep; 478(3):1442-8. PubMed ID: 27569286
[TBL] [Abstract][Full Text] [Related]
6. FAT10 : Activated by UBA6 and Functioning in Protein Degradation.
Pelzer C; Groettrup M
Subcell Biochem; 2010; 54():238-46. PubMed ID: 21222287
[TBL] [Abstract][Full Text] [Related]
7. FAT10ylation as a signal for proteasomal degradation.
Schmidtke G; Aichem A; Groettrup M
Biochim Biophys Acta; 2014 Jan; 1843(1):97-102. PubMed ID: 23333871
[TBL] [Abstract][Full Text] [Related]
8. The proteomic analysis of endogenous FAT10 substrates identifies p62/SQSTM1 as a substrate of FAT10ylation.
Aichem A; Kalveram B; Spinnenhirn V; Kluge K; Catone N; Johansen T; Groettrup M
J Cell Sci; 2012 Oct; 125(Pt 19):4576-85. PubMed ID: 22797925
[TBL] [Abstract][Full Text] [Related]
9. USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.
Aichem A; Pelzer C; Lukasiak S; Kalveram B; Sheppard PW; Rani N; Schmidtke G; Groettrup M
Nat Commun; 2010 May; 1():13. PubMed ID: 20975683
[TBL] [Abstract][Full Text] [Related]
10. The structure of the ubiquitin-like modifier FAT10 reveals an alternative targeting mechanism for proteasomal degradation.
Aichem A; Anders S; Catone N; Rößler P; Stotz S; Berg A; Schwab R; Scheuermann S; Bialas J; Schütz-Stoffregen MC; Schmidtke G; Peter C; Groettrup M; Wiesner S
Nat Commun; 2018 Aug; 9(1):3321. PubMed ID: 30127417
[TBL] [Abstract][Full Text] [Related]
11. The ubiquitin-like modifier FAT10 interferes with SUMO activation.
Aichem A; Sailer C; Ryu S; Catone N; Stankovic-Valentin N; Schmidtke G; Melchior F; Stengel F; Groettrup M
Nat Commun; 2019 Oct; 10(1):4452. PubMed ID: 31575873
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.
Bialas J; Boehm AN; Catone N; Aichem A; Groettrup M
J Biol Chem; 2019 Mar; 294(12):4315-4330. PubMed ID: 30718280
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor mediates USE1-independent FAT10ylation under inflammatory conditions.
Schnell L; Zubrod A; Catone N; Bialas J; Aichem A
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37604583
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic studies on activation of ubiquitin and di-ubiquitin-like protein, FAT10, by ubiquitin-like modifier activating enzyme 6, Uba6.
Gavin JM; Chen JJ; Liao H; Rollins N; Yang X; Xu Q; Ma J; Loke HK; Lingaraj T; Brownell JE; Mallender WD; Gould AE; Amidon BS; Dick LR
J Biol Chem; 2012 May; 287(19):15512-22. PubMed ID: 22427669
[TBL] [Abstract][Full Text] [Related]
15. Structure of UBE2Z Enzyme Provides Functional Insight into Specificity in the FAT10 Protein Conjugation Machinery.
Schelpe J; Monté D; Dewitte F; Sixma TK; Rucktooa P
J Biol Chem; 2016 Jan; 291(2):630-9. PubMed ID: 26555268
[TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-like modifier FAT10 inhibits retinal PDE6 activity and mediates its proteasomal degradation.
Boehm AN; Bialas J; Catone N; Sacristan-Reviriego A; van der Spuy J; Groettrup M; Aichem A
J Biol Chem; 2020 Oct; 295(42):14402-14418. PubMed ID: 32817338
[TBL] [Abstract][Full Text] [Related]
17. Analysis of modification and proteolytic targeting by the ubiquitin-like modifier FAT10.
Aichem A; Boehm AN; Catone N; Schmidtke G; Groettrup M
Methods Enzymol; 2019; 618():229-256. PubMed ID: 30850054
[TBL] [Abstract][Full Text] [Related]
18. Structures of UBA6 explain its dual specificity for ubiquitin and FAT10.
Truongvan N; Li S; Misra M; Kuhn M; Schindelin H
Nat Commun; 2022 Aug; 13(1):4789. PubMed ID: 35970836
[TBL] [Abstract][Full Text] [Related]
19. Dual E1 activation systems for ubiquitin differentially regulate E2 enzyme charging.
Jin J; Li X; Gygi SP; Harper JW
Nature; 2007 Jun; 447(7148):1135-8. PubMed ID: 17597759
[TBL] [Abstract][Full Text] [Related]
20. Parkin is an E3 ligase for the ubiquitin-like modifier FAT10, which inhibits Parkin activation and mitophagy.
Roverato ND; Sailer C; Catone N; Aichem A; Stengel F; Groettrup M
Cell Rep; 2021 Mar; 34(11):108857. PubMed ID: 33730565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
